About Molecular Response
Molecular Response is a company based in San Diego (United States) founded in 2010 was acquired by Bioduro in March 2018. It operates as a B2B. Molecular Response operates in a competitive market with competitors including GenVault Corporation, iSpecimen, PrecisionMed, Cryoniss and AminoChain, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Molecular Response
Detailed funding history for Molecular Response
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Molecular Response
Molecular Response has secured backing from 1 investor. Prominent investors backing the company include Bioduro.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Integrated drug discovery and development services
|
Locked | Locked | Locked |
Investor details for Molecular Response
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Molecular Response
Investment portfolio details for Molecular Response
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Molecular Response
Detailed financials for Molecular Response
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Molecular Response Comparisons
Peer comparison for Molecular Response
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Molecular Response
Molecular Response operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenVault Corporation, iSpecimen, PrecisionMed, Cryoniss and AminoChain, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biosamples are stabilized, transported, stored, and retrieved by GenVault.
|
|
| Locked | Locked | Locked |
Provider of a biorepository of human clinical specimens
|
|
| Locked | Locked | Locked |
Human biological materials for research are supplied via a biorepository.
|
|
| Locked | Locked | Locked |
Provider of biobanking services for life sciences industries
|
|
| Locked | Locked | Locked |
A blockchain-based platform for tokenizing and incentivizing stem cell donations
|
|
| Locked | Locked | Locked |
Provider of services for collecting and preserving umbilical cord blood stem cells
|
Detailed competitors of Molecular Response
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Molecular Response
Complete news archive for Molecular Response
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Molecular Response
Molecular Response was founded in 2010.
Molecular Response is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Molecular Response, founded in 2010 in San Diego, United States, focuses on providing healthcare solutions, advancing biotech innovations, biobanking, and biospecimen storage. Specializes in biospecimen storage and tumor biobanking services. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Molecular Response's top competitors include iSpecimen, AminoChain and GenVault Corporation.
Molecular Response has 1 investor. Key investors include Bioduro.